Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Transcarent vs Vea Health

Transcarent
Graded #445

Higher grade

vs+0.20000000000000284
Vea Health
Graded #450

Lower grade

The verdict

Transcarent takes it — 55.2/100 to 55/100, but only just.

Transcarent grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Transcarent delivers a Weight Health experience for self-insured employers and health plans, combining behavioral coaching, GLP-1 medication management when covered and appropriate, nutrition guidance and… Vea Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationVea Health +11
40
51
Clinical oversightTranscarent +9
75
66
Labs & monitoringTranscarent +9
61
52
FulfillmentVea Health +6
62
68
Contract termsEven
55
55
Transcarent · left barVea Health · right bar

The numbers

MetricTranscarentVea Health
WeighScore55.2/10055/100
GradeCC
Scorecard rank#445#450
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Transcarent

Graded #445 · C

Strengths

  • Comprehensive Weight Health pathway from lifestyle to GLP-1s to surgery
  • Care team of doctors, nurses and pharmacists supports medication use
  • Uses direct pharma contracts and a transparent PBM to cut costs
  • Integrates bariatric surgery navigation alongside medication
  • Built on 15 years of Surgery Center of Excellence experience

Where it loses points

  • Distributed only via employers and health plans, no direct cash-pay
  • GLP-1 access depends on whether the plan covers the medication
  • No public individual monthly pricing
  • Not available to consumers without an eligible employer or plan
Vea Health

Graded #450 · C

Strengths

  • Publishes the FDA compounded-medication disclaimer
  • Oral and injection protocols for both semaglutide and tirzepatide
  • Claims 50-state coverage via a clinician network
  • Clearly differentiated positioning (longevity, men's health, performance)

Where it loses points

  • Pricing not shown until after sign-up
  • Pharmacy partner not named (only 'U.S.-based pharmacy')
  • LegitScript certification status not visible
  • No named medical director
  • 503A vs 503B designation not specified

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard